J7303 – Contraceptive supply, hormone containing vaginal ring, each
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7303
- Long description
- Contraceptive supply, hormone containing vaginal ring, each
- Short description
- Contraceptive vaginal ring
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
SNon-covered by Medicare statute- BETOS category
Z2Undefined codes- Added
- January 1, 2004
- Last change
- October 1, 2021 – No change
- Termination date
- September 30, 2021
Frequently asked questions
What is HCPCS code J7303?
J7303 is a HCPCS Level II code for contraceptive supply, hormone containing vaginal ring, each. It was discontinued on September 30, 2021.
Does Medicare cover J7303?
The HCPCS file lists coverage code S: Non-covered by Medicare statute. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7295 – Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
- J7296 – Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
- J7297 – Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
- J7298 – Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
- J7299 – Intrauterine copper contraceptive (miudella)
- J7300 – Intrauterine copper contraceptive (paragard)
- J7301 – Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302 – Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7304 – Contraceptive supply, hormone containing patch, each
- J7306 – Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 – Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 – Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 – Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 – Ganciclovir, 4.5 mg, long-acting implant
- J7311 – Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 – Injection, dexamethasone, intravitreal implant, 0.1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.